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peripheral sensory neurons as well (Buchman and Da-California Institute of Technology
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In cultured sympathetic neuroblasts, NT-3 not only§Howard Hughes Medical Institute
supports survival; at higher doses it can also promote³Department of Physiology
cell cycle arrest, leading to an induction of tyrosine re-University of California, San Francisco
ceptor kinase A (TrkA) and the appearance of NGF re-San Francisco, California 94143
sponsiveness in embryonic day (E) 14.5 rat sympathetic#Cambridge NeuroScience, Incorporated
neuroblasts (Figure 1B) (Verdi and Anderson, 1994).One Kendall Square
NT-3 also promotes cell cycle withdrawal in corticalCambridge, Massachusetts 02139
neuroepithelial precursors (Ghosh and Greenberg,²Amgen Institute
1995). However, NT-3 is not unique in this action; ciliary620 University Avenue
neurotrophic factor (CNTF) has a similar effect on sym-Toronto, Ontario
pathetic neuroblasts as well (Ernsberger et al., 1989b;Canada
Verdi and Anderson, 1994). Indeed, antimitotic agents
such as aphidicolin and mitomycin C induce TrkA even
more efficiently than high doses of NT-3 and CNTF,Summary
suggesting that expression of this neurotrophin receptor
is primarily a consequence of mitotic arrest (Figure 1B)Neurotrophin 3 (NT-3) can support thesurvival of some
(Verdi and Anderson, 1994).embryonic sympathetic neuroblasts before they be-
Once TrkA is expressed, NGF in turn is able to up-come nerve growth factor dependent. We show that
regulate expression of the low affinity NGF receptor p75NT-3 is produced in vivo by nonneuronal cells neigh-
(Figure 1B) (Wyatt and Davies, 1993; Verdi and Ander-boring embryonic sympathetic ganglia. NT-3 mRNA is
son, 1994). A likely consequence of such increased p75produced by these nonneuronal cells in vitro and is
expression is an enhanced sensitivity to NGF (Davies etup-regulated by platelet-derived growth factor, ciliary
al., 1993; Barker and Shooter, 1994; Hantzopoulos etneurotrophic factor, and glial growth factor 2 (a neu-
al., 1994; Lee et al., 1994; Verdi et al., 1994a). NGF can
regulin). Nonneuronal cell±conditioned medium pro-
also down-regulate TrkC expression in the neuroblasts
motes survival andinduces TrkA expression in isolated
(Figure 1B) (Verdi et al., 1994b) and in this way may
sympathetic neuroblasts, and this activity is blocked
contribute to the switch from NT-3 dependence to NGF
by anti-NT-3 antibody. Neuroblasts also enhance NT-3 dependence. These data illustrate the way in which a
production by nonneuronal cells. Neuroblasts synthe- relay or cascade of neurotrophins and neuropoietic cy-
size several forms of neuregulin, and antibodies to tokines can regulate sequential steps in the survival,
neuregulin attenuate the effect of the neuroblasts on early differentiation, and cell cycle arrest of primary sym-
the nonneuronal cells. Thesedata suggest a reciprocal pathetic neuroblasts in vitro. Similar conclusions have
cell±cell interaction, in which neuroblast-derived neu- been drawn from studies of immortalized sympathoad-
regulins promote NT-3production by neighboring non- renal progenitors (Ip et al., 1994).
neuronal cells, which in turn promotes neuroblast sur- Targeted inactivation of the NT-3 gene by homologous
vival and further differentiation. recombination in mice leads to a 50% reduction in neu-
ronal number in superior cervical sympathetic ganglia
(Ernfors et al., 1994; FarinÄ as et al., 1994). By contrast,
Introduction no such effect on sympathetic development was ob-
served in mice bearing a null mutation in the CNTF gene
Growing evidence indicates that neurotrophins act not (Masu et al., 1993) or in the leukemia inhibitory factor
only as target-derived neuronal survival factors, but also (LIF) gene (Rao et al., 1993), which encodes a cytokine
can regulate mitotic activity and promote differentiation that interacts with a related receptor (Davis et al., 1993).
of neuronal progenitor cells, their survival, or both, in In addition, CNTF expression is low or undetectable in
both the PNS (Sieber-Blum, 1991; Kalcheim et al., 1992; early embryogenesis (StoÈ ckli et al., 1989, 1991). These
Wright et al., 1992) and CNS (Cattaneo and McKay,1990; data provide evidence that NT-3 is important for the
Collazo et al., 1992; Segal et al., 1992; Ghosh and development of at least some sympathetic neurons in
Greenberg, 1995; Vicario-AbejoÂ n et al., 1995). For exam- vivo, although they do not exclude a role for a CNTF-
ple, embryonic rat sympathetic neuroblasts can be sup- related molecule (Leung et al., 1992; Ip et al., 1993).
ported by neurotrophin 3 (NT-3) before they become The demonstration that NT-3 is essential in sympathetic
nerve growth factor (NGF) dependent (Birren et al., 1993; neurogenesis in vivo means that it is important to define
its source and the regulation of its production. Previous
work indicated that NT-3 mRNA can bedetected in form-‖Present address: MCD Biology, Porter Bio-Sciences, University of
Colorado, Boulder, Colorado 80309-0347. ing sympathetic ganglia at E14.5 (Schecterson and
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Figure 1. Schematics Showing the Switch in Neurotrophin Respon-
siveness by Embryonic RatSympathetic Neuroblasts, and the Regu-
latory Circuits Underlying the Switch
Figure 2. Expression of NT-3 in Sympathetic Ganglionic Nonneu-
(A) The switch in neurotrophin responsiveness by embryonic rat ronal Cells In Vivo
sympathetic neuroblasts (Birren et al., 1993; DiCicco-Bloom et al.,
Transverse sections through the thoracic region of E13.5 mouse1993).
embryos containing two copies of the lacZ gene inserted into the(B) The regulatory circuits underlying the switch.
NT-3 locus by homologous recombination. In (A), the sections areThe induction of TrkA expression in neuroblasts exposed to NT-3
counterstained with antibodyto peripherin; arrows indicate the sym-or CNTF appears to be primarily a consequence of mitotic arrest
pathetic ganglia. In (B), the sections are counterstained with anti-(Verdi and Anderson, 1994). In vitro, exposure of TrkA-expressing
body to p75, which reveals nonneuronal cells adjacent to the sympa-neuroblasts to NGF results in both an induction of p75 expression
thetic ganglion. Ao, dorsal aorta; sg, sympathetic ganglion.(Wyatt and Davies, 1993; Verdi and Anderson, 1994) and a down-
regulation of TrkC expression (Verdi et al., 1994b).
neuroblasts by surrounding nn cells and that its produc-
tion in thesecells may in turn beregulated by neuroblast-
derived signals including neuregulins. In this way, a re-Bothwell, 1992); however, these studies did not identify
the cell type(s) that produce NT-3. ciprocal cell±cell interaction mediated by neurotrophins
and neuregulins may control theearly survival and devel-Here we demonstrate that NT-3 is produced by non-
neuronal (nn) cells immediately surrounding sympa- opment of sympathetic neuroblasts.
thetic ganglia, among which are glial progenitors. In
vitro, NT-3 mRNA expression in these nn cells can be Results
strongly up-regulated by glial growth factor 2 (GGF2, a
neuregulin), platelet-derived growth factor (PDGF), and NT-3 Is Expressed in nn Cells Surrounding
Sympathetic GangliaCNTF. The induction of NT-3 mRNA in these nn cells is
paralleled by an increased secretion of survival-promot- To determine the site of NT-3 expression relative to
sympathetic ganglia in vivo, we examined sections ofing and TrkA-inducing activity for sympathetic neuro-
blasts; both such biological activities are inhibited by fetal mice harboring a lacZ gene inserted into the NT-3
locus by homologous recombination (FarinÄ as et al.,blocking anti-NT-3 antibodies. Addition of isolated sym-
pathetic neuroblasts to nn cells also up-regulates NT-3 1994). The expression pattern of b-galactosidase in
these mice reflects the expression of endogenous NT-3mRNA and enhances secretion of neuroblast survival±
promoting activity, which is blocked by anti-NT-3 anti- (I. F., unpublished data). Strikingly, b-galactosidase-
positive cells in these mice surrounded but excludedbody. Freshly isolated sympathetic neuroblasts contain
various forms of neuregulin mRNA. The effect of the sympathetic ganglia primordia as revealed by counter-
staining with antibody to peripherin (Figure 2A, arrows).neuroblasts on nonneuronal cells is attenuated by anti-
GGF/neuregulin antibodies. Taken together, these data The distribution of the b-galactosidase positive cells at
E13.5 overlapped that of cells expressing p75LNGFR, asuggest that NT-3 is provided to embryonic sympathetic
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Figure 3. Expression of NT-3 in Isolated p751 Ganglionic Nonneuronal Cells
Rat E14.5 thoracic sympathetic ganglia were dissociated and sorted by use of anti-p75 monoclonal antibody. The isolated p751 cells were
plated overnight, fixed, and stained with rabbit anti-NT-3 antibody (see Experimental Procedures) at a 1:1000 dilution (A and B) or preimmune
serum at the same dilution as a control (C and D). (A) and (C) are phase contrast micrographs of the bright-field images in (B) and (D),
respectively.
marker of peripheral glia and their neural crest progeni- nonneuronal cells (see Experimental Procedures). Be-
cause of the larger cell numbers obtained, it was moretors (Stemple and Anderson, 1992) (Figure 2B, arrow).
p751 nn cells isolated from rat E14.5 sympathetic gan- convenient to work with B22 cells than p751 cells as a
source of immunoisolated nn cells. These nonneuronalglia by preparative flow cytometry were labeled by an
antibody to NT-3 (see Experimental Procedures; Figure cells were cultured in an insulin-free, serum-free defined
medium in the presence of various growth factors, in-3A and 3B). The expression of NT-3 mRNA in these cells
was independently confirmed by reverse transcription± cluding epidermal growth factor (EGF), insulin-like
growth factor (IGF)-1 and IGF-2, fibroblast growth factorpolymerase chain reaction (RT±PCR) analysis, which
also indicated that NT-3 mRNA was undetectable in (FGF), NGF, brain-derived neurotrophic factor (BDNF),
retinoic acid, and members of the transforming growthneuroblasts isolated with monoclonal antibody B2 (see
below; datanot shown).Thus, both the antibody staining factor-b (TGFb) superfamily. Of these factors, CNTF,
rhGGF2, and PDGF all up-regulated of NT-3 mRNA byand the mRNA analysis confirm that the pattern of
b-galactosidase expression seen in sections likely re- greater than 5-fold after 24 hr (Table 1). No significant
effect was observed with IGF-1, NGF (Table 1), or theflects that of endogenous NT-3 and demonstrates that
this neurotrophin is not expressed by ganglionic neuro- other factors tested (data not shown). By 48 hr, NT-3
mRNA levels were up-regulated over 40-fold (normal-blasts at this stage, but rather by surrounding nn cells,
at least some of which are p751. ized toactin) in rhGGF2- or CNTF-treated cultures (Table
1). Cell number was also dramatically increased in
rhGGF2-treated cultures (not shown); however, the nor-Growth Factors Enhance NT-3 mRNA
Expression and NT-3-Mediated malization to actin indicates that there is a significant
induction of NT-3 on a per cell basis, independent ofBioactivities in Cultured Nonneuronal Cells
We next examined the regulation of NT-3 production in proliferation.
We next asked whether the increase in NT-3 mRNAnn cells isolated from ganglia by negative selection with
monoclonal antibody (MAb) B2 (Birren et al., 1993). The caused by growth factor treatment was correlated with
an enhanced secretion of functional NT-3, as measuredB22 cell population excludes the sympathetic neuro-
blasts and contains the p751 population as well as other by bioassays using conditioned medium (CM) from the
Neuron
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B21 cells. CM from untreated B22 nn cells enhancedTable 1. Relative Levels of NT-3 mRNA in Cultures of B22
Ganglionic Nonneuronal Cells Treated with Various Factors neuroblast survival 2-fold (Table 2, top, no addition, ver-
sus Table 2, bottom, CM [untreated B22 cells]). By 48Factor 24 hr 48 hr
hr, the percentage of surviving neurons in the presence
Control 1.0 6 0.0 1.4 6 0.3 of CM was at least double that seen in controls (Table
IGF-1 1.2 6 0.3 0.8 6 0.2
2; see Table 5). This survival-enhancing effect was abol-NGF 1.5 6 0.3 1.9 6 0.2
ished by adding a function-blocking anti-NT-3 antibodyCNTF 5.2 6 0.4 47 6 2.4
(Ghosh et al., 1994; Ghosh and Greenberg, 1995) to therhGGF2 6.4 6 1.2 43 6 3.8
PDGF 4.8 6 1.6 12 6 1.8 CM (compare Table 2, bottom, CM [B22 cells] plus anti-
B21 neuroblasts 7.1 6 0.8 13 6 1.4 NT-3 with Table 2, top, no addition). The anti-NT-3 anti-
body had no effect on neuroblast survival in basal me-Presented is the mean 6 SEM from two experiments derived from
independent cell isolations. Values represent the levels of NT-3 dium, nor did it reduce neuroblast survival in the pres-
mRNA as assayed by a quantitative RT±PCR procedure. The values ence of insulin (Table 2, top), another survival factor
are normalized to the 24 hr controldeterminations for easier compar- for sympathetic neuroblasts (DiCicco-Bloom and Black,
ison; however, the control cultures contained easily detectable 1988; DiCicco-Bloom et al., 1993; Zackenfels et al.,
amounts of NT-3 mRNA.
1995). These biological controls indicated that the anti-
NT-3 antibody does not inhibit neuroblast survival non-
specifically. These data imply that nn cells constitutively
nn cells. It has been demonstrated previously that re- secrete some NT-3, which is able to enhance neuroblast
combinant NT-3 has at least two biological activities on survival. This conclusion is consistent with the results
isolated B21 sympathetic neuroblasts: at low concentra- of the RT±PCR and immunostaining analyses, in which
tions (0.3±1.0 ng/ml), it can support their survival; at NT-3 mRNA was clearly detectable in untreated nn cells
higher concentrations (30±50 ng/ml), it can promote mi- (Figure 3; see Table 1).
totic arrest and consequent induction of TrkA (Verdi rhGGF2, CNTF, and PDGF all enhanced the neuroblast
and Anderson, 1994). We therefore asked whether these survival-promoting activity of B22 nn cell±CM (prepared
bioactivities were present in nn cell CM and if so whether from 24 hr cultures) by, on average, z50% (Table 2,
they could be inhibited by function-blocking antibodies bottom). Importantly, these factors had no neuroblast
to NT-3 (design illustrated in Figure 4A and 4B). survival±promoting activity on their own (Table 2, top).
In general, rhGGF2 was most effective, consistent withWe first assayed survival in cultures of isolated E14.5
Figure 4. Schematic Diagram Illustrating De-
sign of Conditioned Medium Experiments
Survival or TrkA expression by isolated B21
neuroblasts is measured after culture in the
presence of specific growth factors (A), or
in conditioned media (CM) derived from B22
nonneuronal cells cultured either alone (B) or
in the presence of neuroblasts (C). The CMs
are prepared in the presence or absence of
various growth factors, or in the presence or
absence of blocking antibodies to GGF/neu-
regulin (C). The CMs are applied to the iso-
lated neuroblasts in the presence or absence
of blocking antibodies to NT-3. The survival
or expression of TrkA is measured in the iso-
lated neuroblast preparations.
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Table 2. Neuroblast Survival at 48 hr Promoted by Growth Factors and nn Cell±Conditioned Media
Percentage of Neurons Recovered
Condition Experiment I Experiment II Experiment III
No addition 22 6 4.4 25 6 1.4 15 6 3.5
Anti-NT-3 25 6 1.8 ND ND
NT-3 66 6 7.0 80 6 4.2 75 6 6.2
Anti-NT-3 plus insulin 70 6 2.7 ND ND
rhGGF2 24 6 1.9 28 6 1.9 14 6 0.9
PDGF ND 27 6 0.9 12 6 1.3
CNTF ND 25 6 1.1 16 6 6
CM (untreated B22 cells) 47 6 0.6 69 6 4.7 31 6 4.2
CM (B22 cells) plus anti-NT-3a 22 6 2.1 25 6 4.6 13 6 3.2
CM (B22 cells plus GGF) 67 6 4.4 78 6 1.6 59 6 3.2
CM (B22 cells plus GGF) plus anti-NT-3a 19 6 2.4 24 6 3.9 10 6 5.2
CM (B22 cells plus CNTF) 66 6 3.2 70 6 2.4 49 6 1.6
CM (B22 cells plus PDGF) ND 69 6 3.3 43 6 1.8
The percentage of surviving neuroblasts at 48 hr is indicated. Numbers represent the mean 6 SEM of triplicate determinations of 100±200
cells/well, for each of three independent experiments. B21 neuroblast survival was assayed in presence of purified factors (top), or in conditioned
medium (CM) from B22 nonneuronal cells (bottom). Bottom, conditions in brackets indicate factors present during preculture to produce CM.
The conditions shown at the bottom were tested in parallel with those at the top for each of three independent experiments; therefore the
values at the bottom for each individual experiment should be compared with the control values (no addition) at the top for the corresponding
experiment. ND, not done.
a Anti-NT-3 was added at the time of assay of the CM on the isolated neuroblast cultures. Anti-NT-3 also blocked the activity of CM from
PDGF- and CNTF-treated B22 cells (data not shown). This table shows first of all that CM enhances the survival of neuroblasts; second, that
anti-NT-3 blocks the effect of CM; and third, that GGF, CNTF, and PDGF increase this activity of CM but have no direct effect on neuroblasts
on their own.
the RT±PCR data indicating that this growth factor pro- of theNT-3-independent population may still be affected
by environmental factors or cell±cell interactions.duced the strongest up-regulation of NT-3 mRNA in the
nn cells (see Table 1). Importantly, all the survival-en- We next determined whether nn cell CM could induce
TrkA expression in isolated neuroblasts. CM from B22hancing activity of these growth factor±treated CMs
could be blocked by the anti-NT-3 antibody (Table 2, nn cells pretreated with rhGGF2 or PDGF up-regulated
trkA mRNA expression in isolated B21 neuroblasts (Fig-bottom, CM [B22 cells plus GGF] plus anti-NT-3; data
not shown). These data suggest that rhGGF2, PDGF, ure 5, right; compare GGF, PDGF, with no add). This
CM activity was attenuated by a function-blocking anti-and CNTF all enhance neuroblast survival indirectly, by
increasing the secretion of NT-3 from nn cells. The ap- NT-3 antibody (Figure 5, GGF plus NT-3 AB, PDGF plus
NT-3 AB). The anti-NT-3 antibody didnot affect theTrkA-parent difference between the extent of NT-3 mRNA
induction by GGF at 24 hr (about 6-fold; Table 1), and inducing activity of CM from cells exposed to CNTF
(which has TrkA-inducing activity on its own [Verdi andthe extent of the increase in survival-promoting activity
with GGF-treated CM (50%) likely reflects the fact that Anderson, 1994]); this demonstrates that the antibody
does not interfere nonspecifically with TrkA induction.the amount of additional NT-3 in the CM is saturating
for the survival assay, as indicated by the fact that equiv- As in the survival assay, rhGGF2 had no effect on TrkA
expression when added directly to isolated neuroblastsalent survival was obtained with this CM as with saturat-
ing amounts of recombinant NT-3 (Table 2). Alterna- (Figure 5, left, GGF). These data suggest that rhGGF2
and PDGF promote secretion of sufficient NT-3 fromtively, it could reflect posttranscriptional regulation of
NT-3 synthesis or secretion. nonneuronal cells to induce trkA expression in neuro-
blasts. In contrast, CM from nn cells grownwithout theseIn these experiments, we consistently observed a
population of neuroblasts that survived independentlyof growth factors had little measurable effect on TrkA ex-
pression (Figure 5, right, compare no add with no addNT-3. In two experiments, this basal NT-3-independent
survival was approximately 50% at 24 hr and 23% at 48 plus NT-3 AB). The enhancement of neuroblast survival
(Table 2), but not TrkA expression, by untreated nn cellhr (Table 2, top, experiments I and II, no addition; data
not shown). In a third experiment, in which the neuro- CM most likely reflects the fact that higher levels of
NT-3 are required to induce TrkA expression than toblast plating density was reduced by a factor of 3, basal
survival was 32% at 24 hr and 15% at 48 hr (Table 2, promote survival (Verdi and Anderson, 1994).
top, experiment III, no addition; data not shown). These
data are consistent with the observation of a population
Sympathetic Neuroblasts Contain mRNAof NT-3-independent sympathetic neurons in NT-3 2/2
for Various Neuregulin Isoformsmice (Ernfors et al., 1994; FarinÄ as et al., 1994). The size
The observation that growth factors such as GGF2/neu-of this NT-3-independent population in the superior cer-
regulin and PDGF can up-regulate NT-3 mRNA expres-vical ganglion in vivo is approximately 50% of the total
sion and associated bioactivities in ganglionic nn cellsganglionic neuronal population. These data suggest that
raised the question of whether sympathetic neuroblastsin vitro as in vivo, some embryonic sympathetic neuro-
blasts do not require NT-3 for survival; however, the size could be a source of such NT-3-inducing factors. It has
Neuron
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Figure 5. Conditioned Medium from B22
Nonneuronal Cell Cultures Induces TrkA Ex-
pression in Cultures of Isolated Sympathetic
Neuroblasts, via NT-3
The left of the graph (factor added directly)
shows a series of controls in which factors
or antibodies were added directly to isolated
B21 neuroblasts. Note that NT-3 induces trkA
mRNA, and that the neutralizing anti-NT-3
antibody blocks this effect. In the right of the
graph, expression of TrkA was monitored in
cultures of isolated B21 neuroblasts grown
for 24 hr in various conditioned media from
nonneuronal cultures. No add means that the
conditioned medium was prepared from nn
cultures grown with no added factors. Note
that GGF strongly enhances the TrkA-induc-
ing activity of nn cell CM, although by itself,
GGF has no direct effect on TrkA expression
in isolated neuroblasts (left side of the graph).
The TrkA-inducing activity of the GGF-treated
CM is strongly attenuated by anti-NT-3 anti-
body. A similar result is obtained with PDGF.
The effect of CNTF is, as expected, not
blocked by anti-NT-3, because CNTF itself
has strong TrkA-inducing activity (Verdi and
Anderson, 1994). B21 neurons indicates that
conditioned medium was prepared from a co-
culture of B22 nonneuronal cells and B21 neu-
rons recombined in a 10:1 ratio (see Figure
4C). Note that this CM has much higher TrkA-
inducing activity than control CM (no add)
and that this activity is again attenuated by the blocking anti-NT-3 antibody. The relative levels of trkA mRNA were determined by RT±PCR
and are presented as the percentage of trkA mRNA detected in PC12 cell mRNA samples run in parallel; the numbers are the mean 6 SEM
of replicate samples. Similar results were obtained in two different experiments from separate isolations.
previously been demonstrated that a number of different
CNS and PNS neuronal populations, including embry-
onic sympatheticneurons, make PDGF (Yeh et al., 1991).
Neuregulins have also been demonstrated to be ex-
pressed in the developing nervous system (Marchionni
et al., 1993; Meyer and Birchmeier, 1994; Corfas et al.,
1995), but their expression in sympathetic neuroblasts
at these stages has not specifically been examined.
We therefore assayed neuregulin mRNA production
in isolated E14.5 B21 neuroblasts by RT±PCR. Using
exon I-specific primers that identify mRNA encoding
GGF2 (the form used in the cell culture experiments),
strong signals were detected in E14.5 and E15.5 B21
cells, but were lower in E16.5 and E17.5 cells (Figure 6).
To determine whetherother neuregulin isoformsbesides
GGF2 were expressed in these cells, we performed RT±
PCR with several different primer combinations on
Figure 6. Relative Levels of GGF2/Neuregulin in Freshly Isolated
mRNA isolated from E14.5 neuroblasts. Signals were B21 Sympathetic Neuroblasts
detected by use of primers from the immunoglobulin and cDNA prepared from cells isolated at the indicated ages was ampli-
EGF domains, as well as from the EGF and cytoplasmic fied with exon 1±specific primers that detect the kringle domain of
domains (Table 3). These data, although qualitative, indi- the GGF2 isoform (see Table 3). The values represent the mean 6
SEM of two independent experiments, relative to the level detectedcate that various forms of neuregulins including mem-
at E17.5 after normalization to actin. Levels of GGF2 mRNA at E19.5brane-bound forms are synthesized by embryonic sym-
were below the detection limit of the assay. Note that GGF2 mRNApathetic neuroblasts. Importantly, little or no neuregulin
was not detectable in samples of B22 nonneuronal cell cDNA run
mRNA was amplified from E14.5 B22 nn cell cDNA (data in parallel. Qualitative results obtained with other neuregulin primer
not shown). sets are presented in Table 3.
Endogenous Neuregulins Enhance Neuroblast
Survival in Cocultures enhance NT-3 production in nonneuronal cells, sug-
gested that neuroblast-derived neuregulins might en-with Nonneuronal Cells
The observations that sympathetic neuroblasts are a hance neuroblast survival in cocultures with nonneu-
ronal cells. To test this idea, we recombined isolatedpotential source of neuregulins, and that neuregulins
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of a portion of the neuroblasts (Table 4, anti-NT-3). Im-Table 3. Expression of Neuregulin Isoforms by Isolated E14.5
portantly, function-blocking antibodies to GGF2/neu-B21 Sympathetic Neuroblasts
regulin (see Experimental Procedures) also inhibitedPrimer Set Exon Pairs Expression Detected
neuroblast survival (Table 4). However, at 48 hr, the
59 kringle±39 kringle 1±1 11 reduction in survival with anti-GGF was not as great
59 Ig±39 EGF 4±6 1 as with anti-NT-3. This finding is consistent with the
59 Ig±39 Cyt 4±11 2
observation that nn cells make some NT-3 even in the59 Ig±39 Sec 4±10 2
absence of sources of GGF/neuregulin (see above).59 kringle±39 Sec 1±10 1/2
These data suggested that endogenous sources of59 EGF±39 Cyt 6±11 111
59 EGF±39 Sec 6±10 2 neuregulin can enhance neuroblast survival in cocul-
tures containing nonneuronal cells. We therefore next
asked whether neuroblasts enhance NT-3 synthesis in
nonneuronal cells via neuregulins.
Neuroblasts Up-regulate NT-3 mRNA
Expression in Nonneuronal Cells
via Neuregulins
RT±PCR was performed on cDNA prepared from E14.5 B21 neuro- B21 neuroblasts were recombined with B22 nonneu-
blasts, using the indicated primer pairs. The results of the amplifica- ronal cells in a 1:10 ratio, and the expression of NT-3
tion were visualized by agarose gel electrophoresis with ethidium
mRNA in these cocultures was subsequently measuredbromide staining. Band intensities are approximated by plus and
by RT±PCR. After 48 hr, NT-3 mRNA levels were 13-foldminus symbols. The strongest signal was obtained for a membrane-
higher in such cocultures than in sister cultures of nnbound form containing the EGF-like domain (59 EGF±39 Cyt). Loca-
tions and orientations of the primers used are indicated in the dia- cells grown alone (see Table 1, B21 neuroblasts). To
gram; 59 primers point rightwards, 39 primers leftwards. Exon num- determine whether the NT-3 mRNA produced in these
bers are indicated below the boxes in the diagram, and domains cocultures was derived from the nn cells, the neuro-
are overlined. blasts were removed from the nn cells by use of EDTA
Neuregulin domain abbreviations: kringle, exon 1 (specific to
(see Experimental Procedures), and both cell popula-rhGGF2); Ig, immunoglobulin-like domain, exon 4; EGF, EGF repeat
tions were assayed for NT-3 mRNA by RT±PCR. A strongdomain, exon 6; Cyt, cytoplasmic domain, exon 11 (transmembrane
NT-3 signal was detected in the nn cell cDNA, whereasform); Sec, putative secreted form with stop codon before trans-
membrane segment, exon 10. no signal was detected in similar amounts of neuroblast
cDNA amplified for the same number of cycles (data not
shown). These data are consistent with our finding that
NT-3 mRNA is detectable by RT±PCR in freshly isolatedB21 neuroblasts together with B22 nonneuronal cells in
B22 but not B21 cells from E14.5 ganglia (see above).a ratio (1:10) reflecting their relative proportions in
Thus, these coculture experiments suggest that B21freshly sorted cell suspensions, and monitored neuro-
neuroblasts, as well as rhGGF2, PDGF, and CNTF, canblast survival. To exclude possible contributions of de
up-regulate NT-3 mRNA production by B22 nn cells.novo neurogenesis to overall neuronal number, cohorts
To determine whether the effect of B21 neuroblastsof individual neuroblasts were identified several hours
in up-regulating NT-3 mRNA production in nn cells wasafter plating and their survival followed with time.
mediated by endogenous neuregulins, we examinedOverall neuroblast survival in the cocultures at 24 hr
NT-3 mRNA levels in cocultures grown with or withoutwas 77% 6 4.9% (Table 4), much better than the 45%±
the function-blocking anti-GGF2/neuregulin antibody. In50% observed when B21 neuroblasts are cultured in
control experiments, the antibody strongly attenuatedisolation at the same density (see above). Inclusion of
the up-regulation of NT-3 mRNA by rhGGF2, but had noanti-NT-3 antibodies in the cocultures inhibited survival
effect on NT-3 mRNA up-regulation by PDGF (Figure
7), demonstrating the specificity of the inhibition. Anti-
Table 4. Survival of Serially Observed Cohorts of B21 Cells in GGF2/neuregulin also attenuated the up-regulation of
Coculture with B22 Nonneural Cells under Various Conditions NT-3 mRNA caused by coculture with E14.5 B21 neuro-
blasts (Figure7, compare B21 neurons with B21 neuronsPercentage of Neurons
Surviving plus GGF AB). This indicated that the neuroblast en-
hancement of NT-3 mRNA production in nonneuronalCondition 24 hr 48 hr
cells is, at least in part, mediated by neuregulins. The
Control 77 6 4.9 63 6 9.2 failure of the antibody to produce a quantitative inhibi-
rhGGF2 82 6 3.8 78 6 1.6 tion of either the neuroblast- or rhGGF2-mediated effect
Anti-GGF 59 6 7.4 51 6 11.2
(Figure 7) suggests that the antibody may not have beenAnti-NT-3 52 6 8.2 30 6 2.4
saturating, or that not all neuregulin isoforms areAnti-GGF plus rhGGF2 79 6 3.8 73 6 1.4
blocked; alternatively, the neuroblasts may produceAnti-GGF plus insulin 93 6 0.7 86 6 0.8
Anti-NT-3 plus insulin 81 6 13.5 88 6 2.8 other NT-3-inducing signals (e.g., PDGF) not inhibited
by the antibody.For each of the above conditions, 100±150 neuroblasts were identi-
fied in each of three plates (for a total of 300±450 neurons per
Neuroblast-Derived Neuregulins Promotecondition), at 2 hr after plating. The survival of these identified cells
was monitored at 24 hr and at 48 hr. The percent survival relative Up-regulation of NT-3-Mediated
to 2 hr after plating was calculated for each plate; the mean 6 SEM Bioactivities Secreted by Nonneuronal Cells
of these percentages is indicated in the table. At 48 hr, the data are We next sought to determine whether the neuroblast
from duplicate rather than triplicate plates.
enhancement of NT-3 mRNA expression in nn cells was
Neuron
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plus B21] plus anti-NT-3). Taken together, these data
indicate that neuroblasts not only enhance the expres-
sion of NT-3 mRNA in nn cells, but also promote the
secretion of NT-3-dependent bioactivities by thesecells.
Finally, we asked whether the anti-rhGGF2/neuregulin
antibody eliminated the enhanced secretion of survival-
promoting activity by cocultures of neuroblasts and non-
neuronal cells. For this experiment, cocultures of B22
and B21 cells were allowed to condition their medium
in the presence or absence of anti-rhGGF2 antibody;
the survival activity of CM from these cultures was then
compared with that of CM from untreated nn cell cul-
tures (design illustrated in Figure 4C). In three indepen-
dent experiments, pretreatment with the anti-GGF/neu-
regulin antibody attenuated the survival-promoting
activity of the coculture-derived CM (Table 5, compare
CM [B22 plus B21 plus anti-GGF] with CM [B22 plus
B21 cells, 10:1]). Moreover, in two of three experiments,
the anti-GGF antibody reduced the survival-promoting
activity of the coculture CM to almost exactly that seen
with CM from untreated nn cell cultures (Table 5, experi-
ments I and III; compare CM [untreated B22 cells] with
CM [B22 plus B21 plus anti-GGF]). Control experimentsFigure 7. Induction of NT-3 mRNA in Nonneuronal Cells by Cocul-
indicated that the antibody effect was overcome by ad-ture with Neuroblasts Is Attenuated by Neutralizing Anti-GGF
dition of excess rhGGF2 (Table 5, CM [B22 plus B21Antibody
plus anti-GGF plus GGF]). Additional controls showedRelative NT-3 mRNA levels in cultures of B22 nonneuronal cells
grown under different conditions for 24 hr were determined by RT± that the anti-GGF2/neuregulin antibody had no effect
PCR (see Table 1) and normalized to actin mRNA levels. rhGGF2 on neuroblasts grown in basal medium, or in medium
strongly up-regulates NT-3 (see also Table 1), and this effect is containing insulin (provided to enhance survival by an
attenuated by anti-GGF antibody. By contrast, the up-regulation of
NT-3-independent means) (data not shown). Taken to-NT-3 obtained with PDGF is unaffected by the anti-GGF antibody.
gether, these data indicated that neuroblast-derivedNT-3 mRNA levels are also up-regulated by coculture with B21 neu-
neuregulin not only promotes NT-3 mRNA synthesis inroblasts, and this effect is also attenuated by the anti-GGF antibody.
The data represent the average 6 SEM of two independent experi- nn cells, but also increases secretion of NT-3-dependent
ments. neuroblast survival activity from the nn cells.
Discussion
accompanied by an increased secretion of NT-3-depen-
dent bioactivities. Therefore, both TrkA induction and Recent studies have established that developing rat
neuroblast survival assays were performed on neuro- sympathetic neuroblasts undergo a switch in neuro-
blasts cultured in CMs derived from untreated B22 nn trophin responsiveness (Birren et al., 1993; DiCicco-
cells, or from cocultures of B22 nn cells and neuroblasts Bloom et al., 1993). At E14.5±E15.5, neuroblasts in both
(design illustrated in Figure 4B and 4C). As shown in thoraco-lumbar and superior cervical ganglia express
Figure 5, conditioned medium from cocultures up-regu- TrkC and respond to NT-3, but do not express TrkA.
lated trkA expression in isolated B21 neuroblasts, Beginning at about E16.5, these cells begin to express
whereas little effect on TrkA expression was observed TrkA and acquire NGF responsiveness as measured by
with CM from nn cells alone (see Figure 5, compare B21 24 hr survival assays. Over the same period of time, TrkC
neurons with no add). The effect of the coculture CM expression by these cells declines, and they become
was attenuated by anti-NT-3 antibody (see Figure 5, B21 relatively less sensitive to NT-3 in similar survival assays
neurons plus NT-3 AB). This suggests that most or (Figure 1). Similar switches in neurotrophin receptor ex-
all of the TrkA-inducing activity in CM derived from pression have been documented in developing sensory
cocultures of neuroblasts and nonneuronal cells is due neurons as well (Buchman and Davies, 1993; Buj-Bello et
to NT-3. al., 1994; Davies, 1994). The observation that immature
CM from cocultures also enhanced neuroblast sur- neurons or neuroblasts are transiently responsive to
vival more effectively than did CM from untreated nn neurotrophins that differ from their ultimate target-
cells (Table 5, CM [untreated B22 cells] versus CM [B22 derived survival factors raises the question of the source
plus B21 cells, 10:1]; experiments I and III). In one of three and regulation of production of these interim trophic
independent experiments, coculture and untreated nn factors.
cell CM enhanced survival to a similar extent (Table 5, Here we show that NT-3 is synthesized by nn cells
experiment II), but the nn cell CM had a higher level of neighboring sympathetic ganglia, and that in vitro, these
survival-promoting activity to begin with than it did in cells can provide sufficient NT-3 to promote survival
the other experiments (Table 5, row 2). Importantly, all and TrkA induction in isolated neuroblasts (Figure 8A,
the survival-promoting activity of the coculture CM was top). In turn, the neuroblasts can enhance NT-3 produc-
tion in the nn cells in vitro, via neuregulins and perhapsinhibited by the anti-NT-3 antibody (Table 5, CM [B22
Cell±Cell Interactions Control Sympathetic Development
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Table 5. Neuroblast Enhancement of Secretion of NT-3-Mediated Neurotrophic Activity from Nonneuronal Cells Is Dependent upon
Endogenous Neuregulins
Percentage of Neurons Recovered
Condition Experiment I (%) Experiment II (%) Experiment III (%)
No addition 22 6 4.4 25 6 1.4 15 6 3.5
CM (untreated B22 cells) 47 6 0.6 (113.6) 69 6 4.7 (176) 31 6 4.2 (138)
CM (B22 plus B21 cells, 10:1) 56 6 0.2 (154) 70 6 2.8 (180) 44 6 4.2 (193)
CM (B22 plus B21) plus anti-NT-3 21 6 1.8 (0) 25 6 3.7 (0) 13 6 1.9 (0)
CM (B22 plus B21 plus anti-GGF) 47 6 2.2 (113.6) 36 6 4.5 (44) 35 6 3.5 (133)
CM (B22 plus B21 plus anti-GGF plus GGF) 72 6 2.5 (188) 56 6 2.8 (273)
The percentage of surviving neuroblasts at 48 hr is indicated. B21 neuroblast survival was assayed in control medium (no addition), or in
conditioned medium (CM) from B22 nonneuronal cells precultured alone (untreated B22 cells) or together with B21 neuroblasts in a 10:1 ratio
(B22/B21). The data in the first two rows are taken from Table 2. Row 4, anti-NT-3 was added at the time of assay of the CM on the isolated
neuroblast cultures. Rows 5 and 6, anti-GGF indicates that anti-GGF2 antibody was added to the cocultures at the time of plating (see Figure
4C). Numbers in parentheses indicate the percent increase over control (no addition) observed in each CM condition. This is calculated as
([% survival in CM 2 % survival in no addition] 4 % survival in No Addition) 3 100. All percent increases were statistically significant (p >
.034) as determined by a 2-tailed Student's t test. Note that while CM from cultures of B22 cells alone enhances survival (by 113.6%±176%),
CM from cocultures of B22 and B21 cells is more efficacious (by 154%±193%) (except in Experiment II, in which a higher basal level of survival
activity in B22 CM was obtained). This greater efficacy is eliminated by inclusion of anti-GGF antibody during the preparation of CM, and the
antibody effect is reversed by inclusion of excess recombinant human GGF. Anti-GGF antibody had no effect on CM from nonneuronal cells
grown in the absence of neuroblasts (data not shown).
other factors, such as PDGF (Figure 8A, bottom). These this cell population. However, RT±PCR measurements
indicated that NT-3 transcripts are enriched at least 10-cell culture experiments thus demonstrate how a recip-
rocal cell±cell interaction can coordinate the develop- fold in isolated p751 cells, compared with levels in B22
cells (after normalization to actin; data not shown).ment of embryonic sympathetic neuroblasts and their
neighboring nonneuronal cells (Figure 8B). The appro- These observations are consistent with the idea that
p751 cells are the major if not the only source of NT-3priatespatial and temporal expression of NT-3, neuregu-
lins, and PDGF (Yeh et al., 1991) suggests that this inter- in the B22 fraction. Taken together, these data support
the idea that at least some of the NT-3-expressing nnaction reconstituted in vitro may reflect normal
developmental events that occur in vivo. Bidirectional cells are glia or their precursors. However, it is possible
that some nonglial mesenchymal cells in the vicinity ofinteractions between neuroblasts and glia have also
been observed in studies of cerebellar development sympathetic ganglia express NT-3 as well and contrib-
ute to the local support of neuroblast survival.(Hatten, 1987, 1988), although the molecules involved
on both sides of the interaction have not been fully It iswell documented that neurotrophins are produced
by peripheral targets of sympathetic and sensory in-identified. Such reciprocal cell±cell interactions in the
developing nervous system may provide general exam- nervation, where they function to support the survival
of adequate numbers of neurons during the period ofples of how the development of tissues containing sev-
eral distinct but functionally interrelated cell types is programmed cell death. The above mentioned data indi-
cate that neurotrophins are also synthesized by nonneu-coordinated.
ronal cells located near the cell bodies of developing
sympathetic neuroblasts. This supports our earlier sug-
gestion that NT-3 may function to provide local, interimGanglionic Nonneuronal Cells Produce
trophic support for embryonic sympathetic neuroblastsInterim Neurotrophins for Embryonic
before these cells express functional NGF receptors andSympathetic Neuroblasts
gain access to target-derived NGF (Birren et al., 1993).The insertion of a lacZ gene into the NT-3 locus by
This view is consistent with the idea that most or allhomologous recombination has allowed us to visualize
cells in the body require trophic support at multiplethe pattern of NT-3 expression in tissues neighboring
stages of development as well as in the adult (Raff,the developing thoraco-lumbar sympathetic ganglia.
1992). The acquisition of NGF dependence would thenThe domain of lacZ-expressing cells excluded the gan-
occur, in part, by a substitution of a target-derived neu-glionic neuroblasts and overlapped that of cells ex-
rotrophinÐNGFÐfor the interim neurotrophinÐNT-3Ðpressing p75, a marker of peripheral glia and their neural
provided to the neuroblast cell bodies. In addition, NGFcrest precursors (Stemple and Anderson, 1992; Shah et
is likely to be provided by glial cells lining the pathwayal., 1994). Analysis of fluorescence-activated cell sorter
taken by sympathetic axons to their peripheral targets(FACS)-isolated p751 cells confirmed that these cells
(Johnson et al., 1988). Such a model does not excludeexpress NT-3 protein and mRNA. Freshly isolated p751
the possibility that sympathetic neuroblasts are neuro-cells are glial fibrillary acidic protein±negative (GFAP2),
trophin independent at yet earlier stages of develop-but can express GFAP when cultured in rhGGF2 plus
ment; evidence for this has been provided in the chickserum (data not shown). This suggests that these cells
system (Ernsberger et al., 1989a). Evidence for a neuro-are glial precursors, neural crest cells or both. Because
trophin-independent stage in sensory neurogenesis hasp751 cells constitute only 10%±15% of B22 cells, we
cannot say that they are the only source of NT-3 in been provided as well (Vogel and Davies, 1991).
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isoforms in these cells was not undertaken. The fact that
CM from B21 neuroblasts did not induce NT-3 mRNA,
whereas direct contact between these neuroblasts and
the nn cells did, suggests that at least some of the NT-
3-inducing activity provided by the neuroblasts may be
membrane associated. In keeping with this, neuregulins
are alternatively spliced to generate several membrane-
associated isoforms, and we observe expression of the
cytoplasmic domain±containing exon (i.e., a transmem-
brane form) in the neuroblasts by RT±PCR. However, it is
possible that sympathetic neuroblasts also make some
secreted forms of neuregulins, which did not accumu-
late to sufficient levels in conditioned medium from the
low-density cultures, to influence NT-3 expression in
nonneuronal cells.
Sympathetic neuroblasts are not the only neuronal
cells that could provide a source of GGF/neuregulin for
NT-3-expressing nn cells in the vicinity of the sympa-
thetic ganglia. The preganglionic afferent nerves that
grow to these ganglia contain the axons of motorneu-
rons, which have also been shown to express various
neuregulin isoforms, including ARIA, an acetylcholine
receptor-inducing activity for skeletal muscle (Falls et
al., 1993; Corfas et al., 1995). These preganglionic fibers
pass through thearea containing lacZ1 NT-3-expressing
cells and could therefore be an additional source of NT-
3-inducing signals. Motor neurons also contain PDGF
mRNA (Sasahara et al., 1991; Yeh et al., 1991). The multi-
plicity of signals that can induce NT-3 in vitro makes it
Figure 8. Summary of Experimental Observations and Model for difficult to predict which, if any, of these signals will
Reciprocal Cell±Cell Interactions Controlling Early Stages in Sympa- prove to be essential for NT-3 expression in vivo as
thetic Gangliogenesis determined by single-gene mutational analysis.
(A, top) Illustration of the data indicating first of all that NT-3 pro-
motes neuroblast survival and mitotic arrest/TrkA expression (see
also Verdi and Anderson, 1994); second, that B22 ganglionic non-
Function of NT-3 during Sympatheticneuronal cells also promote neuroblast survival and TrkA expression
Neurogenesis In Vivo(and express NT-3); and third, that blocking anti-NT-3 antibodies
Previously, we demonstrated that NT-3 can exert a dualinhibit the survival-promoting and TrkA-inducing activities in condi-
tioned medium from nonneuronal cells. influence on developing sympathoblasts in vitro: it can
(A, bottom) Illustration of the data indicating first of all that GGF and support their survival and in addition can induce the
PDGF (as well as CNTF) up-regulate NT-3 expression in nonneuronal expression of the NGF receptor TrkA, as a consequence
cells; second, that neuroblasts also up-regulate NT-3 expression in
of promoting cell cycle withdrawal (Verdi and Anderson,non-neuronal cells (and themselves express forms of GGF/neuregu-
1994). Previous analyses of NT-32/2 mice have providedlin as well as PDGF [Yeh et al., 1991]); and third, that blocking anti-
evidence that NT-3 is indeed required by at least a sub-GGF antibodies inhibit the ability of neuroblasts to up-regulate NT-3
expression in nonneuronal cells. set of sympathetic neurons in vivo, although the precise
(B) Reciprocal cell±cell interactions that occur in vitro between neu- stage of development at which this neurotrophin is
roblasts and nonneuronal cells as suggested by the data. needed has not yet been determined (Ernfors et al.,
1994; FarinÄ as et al., 1994). On the other hand, in prelimi-
nary experiments we have observed that TrkA is ex-Regulation of NT-3 Production in nn Cells
NT-3 mRNA expression and the secretion of NT-3- pressed in the sympathetic ganglia of NT-32/2 mice
(I. F., unpublished data). This may indicate that NT-3 isdependent biologic activities in nn cells can be strongly
up-regulated by environmental signals, including GGF2, only one of several functionally redundant factors that
can induce TrkA expression in sympathetic neuroblasts;PDGF, and CNTF. Earlier data as well as the present
results suggest that in vivo, PDGF and GGF/neuregulin indeed, we have shown that at least one other factor,
CNTF, induces TrkA expression in vitro as efficiently asmay be produced by sympathetic neurons neighboring
the nonneuronal cells. PDGF is well known to be synthe- NT-3 (Verdi and Anderson, 1994). Moreover, both CNTF
and NT-3 promoted mitotic arrest of sympathetic neuro-sized by a large number of neurons, including embryonic
sympathetic neurons (Sasahara et al., 1991; Yeh et al., blasts, and mitotic inhibitors such as aphidicolin and
mitomycin C were also effective inducers of TrkA (Verdi1991). Previous work has shown that embryonic sympa-
thetic ganglia contain at least some forms of neuregulin and Anderson, 1994). These data suggested that the key
event promoting the appearance of TrkA in sympathetic(Marchionni et al., 1993; Meyer and Birchmeier, 1994).
Here we have demonstrated that sympathetic neuro- neuroblasts is cell cycle withdrawal. While NT-3 may
accelerate this process in vitro, the timing of mitoticblasts synthesize several forms of neuregulin, including
GGF2, although a quantitative analysis of neuregulin arrest in vivo may be determined by other environmental
Cell±Cell Interactions Control Sympathetic Development
525
Neutralizing Antibodiessignals or by a cell-autonomous mechanism (e.g., see
Turkey anti-NT-3 antibody was a gift from Amgen, Incorporated andHart et al., 1989).
has been previously demonstrated not to cross-react with otherIn summary, our results demonstrate that a neuro-
neurotrophins (Ghosh et al., 1994; Ghosh and Greenberg, 1995).
trophic factor that acts on immature neuroblasts is pro- This antibody was used at a final concentration of 580 ng/ml, which
duced by nonneuronal cells neighboring these neuro- was 10-fold higher than the amount needed to block the survival-
promoting activity of 40 ng/ml NT-3. In the experiment of Figure 3,blasts, and that its production in these cells can in turn
a polyclonal rabbit anti-NT-3 antibody (the gift of D. Kaplan) wasbe regulated by neuroblast derived signals in vitro. While
used for immunostaining at a dilution of 1:1000. This antibody isthe experiments identify some of the signals that are
monospecific for NT-3 in Western blots (D. Kaplan, personal com-necessary and sufficient to mediate this interaction in
munication). Anti-GGF was a cocktail of two antibodies: CN16, an
culture, the situation in vivo may be considerably more affinity-purified polyclonal antiserum raised against intact rhGGF2
complex. Nevertheless, the results illustrate the kind of and used at a final concentration of 20 mg/ml; and 2861, an affinity-
purified polyclonal antibody raised against an exon I±specific pep-reciprocal cell±cell interactions that can occur between
tide, used at 12 mg/ml. This amount of antibody was sufficient toneuronal and glial precursors in developing peripheral
block completely the activity of 10±20 ng/ml rhGGF2 in a Schwannganglia. They also shed further light on how neurotroph-
cell DNA synthesis assay. A detailed characterization of these anti-ins may regulate neuronal survival and differentiation in
bodies will be reported elsewhere (N. Ratner et al., submitted). Anti-
the period before these cells gain access to classical GGF antibody was added to cocultures of neuroblasts plus nn cells
target-derived trophic factors. and was preincubated with the neuroblasts prior to plating to facili-
tate binding to cell surface±associated forms of GGF/neuregulin.
Experimental Procedures
RT±PCR
Conditions for RNA extraction, cDNA synthesis, and RT±PCR forCell Isolation and Culture
trkA and actin were as described previously (Verdi and Anderson,Sympathetic neuroblasts and associated ganglionic nonneuronal
1994). RT±PCR for NT-3 was performed with the following primerscells were isolated from E14.5 thoraco-lumbar sympathetic ganglia
and amplification conditions. Forward primer, AGG TGA TGT CCAusing MAbB2 for both positive and negative selection, as previously
TCT TGT TTT; reverse primer, GCC TCT CCC TGC TCT GGT TC.described (Birren et al., 1993; Verdi and Anderson, 1994). In some
Conditions employed a hot start, 1 min at 978C, 1 min at 528C, 1experiments, p751 cells were isolated by preparative FACS using
min at 728C for 35 cycles. For all quantitative measurements, inputmonoclonal antibody 192 Ig. No neurons were ever observed in p75-
cDNA levels were normalized with actin primers (Verdi and Ander-sorted cells; therefore, 100% of the p751 cells must be contained
son, 1994). RT±PCR for various isoforms of GGF/neuregulin waswithin the B22 nonneuronal fraction. RT±PCR determinations indi-
performed under the conditions described previously (Shah et al.,cated that NT-3 transcripts are enriched at least 10-fold (relative to
1994). Exact primer sequences used are available on request.actin transcripts) in the p751 fraction compared with the B22 frac-
tion. Since p751 cells constitute about 7%±12% of the B22 fraction,
Growth Factorsthis suggests that most if not all of the NT-3 synthesized by the B22
Recombinant NT-3 and CNTF were obtained from Amgen, Incorpo-fraction is synthesized by p751 cells within this fraction. However,
rated and Regeneron, Incorporated, respectively, and were used atbecause of the larger cell numbers obtained, it was more convenient
final concentrations of 25 and 2 ng/ml, respectively. rhGGF2 wasto work with B22 cells than p751 cells as a source of immunoisolated
obtained from Cambridge NeuroScience, Incorporated and wasnonneuronal cells.
used at concentrations that gave maximal activity in a Schwann cellFor assays of TrkA expression and survival in isolated neuroblasts,
DNA synthesis assay (typically 10 nM). Recombinant PDGF wastypically 3,000 cells were plated per well of a 96-well plate on a
from Sigma and was used at a final concentration of 20 ng/ml.poly-D-lysine/laminin substrate, in 100 ml of defined, serum-free
medium (L15±CO2 containing transferrin, selenium, putrescine, pro-
gesterone, and bovine serum albumin). Determinations of neuronal Analysis of NT-32/2 Mice
survival were made by manually counting the number of neurons Mice containing the lacZ gene inserted into the NT-3 locus by homol-
at 24 and 48 hr and expressing the results as a percentage relative ogous recombination have been described previously (FarinÄ as et
to the number of cells that attached 2±3 hr after plating. Duplicate al., 1994). Embryos were genotyped by DNA blot analysis and pro-
or triplicate determinations were made for each experiment. The cessed by cryostat sectioning for detection of b-galactosidase ac-
results are presented as the mean 6 SEM. tivity with the X-Gal reagent, followed by immunostaining for periph-
In some experiments, neuroblasts and nonneuronal cells were erin (antibody from Sigma, Incorporated) or p75 (antibody Rex;
reseparated following coculture according to the following proce- Weskamp and Reichardt, 1991).
dure. Cultures were treated with Hanks' balanced salt solution
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